⚠️Disclaimer: For educational purposes only. Not SEBI-registered. Not a buy/sell recommendation. Do your own due diligence before investing. We may or may not have vested interest in the stocks discussed.

SME in 6 Cards/Healthcare/Nephro Care India Ltd
SME in 6 Cards

Nephrologist-founder builds East India's kidney care chain — now launching transplants and eyeing 300-clinic national footprint

From a single Kolkata clinic doing ₹1.82 Cr (FY21) to a 150-bed hospital + 5 dialysis centres doing ₹46 Cr (FY25) — all debt-free

K

KnowYourSME Research

2026-05-10 · 12 min

₹46 Cr
Revenue FY25 (+69% YoY)
₹53.5 Cr
Net Worth (Zero Debt)
25x
Revenue Growth FY21→FY25
150 Beds
Hospital + 5 Clinics

The business

Nephro Care India is a Kolkata-based nephrology-focused healthcare company operating a hub-and-spoke network of dialysis clinics and a multispecialty hospital. Founded in 2014 by Dr. Pratim Sengupta (DNB Nephrology, 1,000+ kidney transplants), the company serves CKD/ESRD patients through recurring dialysis sessions, integrated pharmacy, and hospital inpatient services. Revenue model: OPD dialysis (52%), pharmacy (25%), IPD hospital (23%).

HealthcareDialysis & Nephrology

Why this business matters

Massive CKD undertreatment — India has 17 Cr patients with 10-15% penetration. 2.5 lakh new patients annually. Global dialysis market $5B→$11.3B by 2033

Kidney transplant launch — license obtained May 2025. Only 13,642 performed vs 2 lakh demand. Commencing Q3 FY26 — high-margin growth vertical

PPP & partnership model — India's first central govt-private healthcare PPP with Metro Railway. Asset-light franchise model planned for 300-clinic national expansion

The moat

Revenue 25x
₹1.82→₹46 Cr
FY21 to FY25 with zero debt
Founder Moat
1,000+ Transplants
DNB Nephrologist — clinical credibility impossible to replicate
Hospital
₹36.51 Cr Invested
150 beds, AI-powered OTs, expanding to 250
OCF Surge
+759% YoY
₹0.91→₹7.82 Cr. Debt-free, ₹20.65 Cr liquid

Reality check

Extreme founder dependency — MD, CEO, largest shareholder (60.71%), and primary clinician. No succession plan

Margin compression — EBITDA 25.1%→16.1%, PAT -17.5% despite 69% revenue growth. Hospital at 40% occupancy

Geographic concentration — almost all revenue from West Bengal. Mumbai/Jharkhand at lease/agreement stage only

Fresenius trademark fight — global #1 dialysis company opposing Nephrocare India mark. Rebranding risk

🚪

Exit Trigger

Hospital occupancy stagnates below 50% beyond FY27, or Dr. Pratim Sengupta reduces involvement, or geographic expansion fails to generate revenue outside West Bengal within 18 months

The verdict

7/10 — Visionary Founder Healthcare Play. Compelling disease-burden tailwind + nephrologist-founder moat + 25x revenue growth. But FY25 margin compression, 40% hospital occupancy, and extreme founder dependency require patience. Kidney transplant launch (Q3 FY26) and 60%+ occupancy are key re-rating catalysts.

Watch For

Q3 FY26 kidney transplant commencement, hospital occupancy crossing 60%, Bandra Mumbai unit becoming operational, and EBITDA margin recovery above 20%

Want the full story?

Read our comprehensive 7-chapter Deep Dive with financials, management analysis, IPO tracker, and more.

Read Full Deep Dive

Can a nephrologist-founder scale a regional kidney care chain into a national healthcare platform while maintaining clinical quality?

Share your view in the comments below

Disclaimer: For educational purposes only. Not SEBI-registered. Author may hold positions in stocks discussed. Not a buy/sell/hold recommendation. Do your own due diligence.

More SME in 6 Cards

Airport Infrastructure

Anlon Technology Solutions Ltd

India's only Make in India fire truck manufacturer with 7 exclusive global OEM partnerships

Precision Engineering

Sunita Tools Ltd

From mould bases to 155mm artillery shells — India's boldest SME defence pivot

Precision Engineering

Apsis Aerocom Ltd

This Bangalore micro-cap makes precision parts for global aerospace & defence OEMs

Defence HVAC & Refrigeration

Shree Refrigerations Limited

India's only naval HVAC company with all 3 defence registrations — now entering data centre cooling

Pharma Packaging

GSM Foils Ltd

₹258 Cr revenue in just 2 years — but where's the cash?

Cables & Wires

Prime Cable Industries Ltd

₹235 Cr revenue, ₹217 Cr order book — riding India's power infra boom

Transformers

Supreme Power Equipment Ltd

₹578 Cr order book, 20% EBITDA margins — this transformer maker is scaling 8x

Healthcare

Invicta Diagnostic Ltd

MMR's hub-and-spoke PET-CT diagnostic chain — 90% revenue growth with 32% EBITDA margins

Defence & Aerospace

Digilogic Systems Limited

India's defence ATE specialist with AS9100D certification — EBITDA margins doubled to 18.6% in FY25

Electrical Equipment

JD Cables Limited

From ₹41 Cr to ₹251 Cr in 2 years — 150% CAGR cable manufacturer now pivoting to ₹407 Cr EPC infrastructure

Railway Equipment

Kalyani Cast Tech Limited

IIT Madras founder builds India's import-substituting container maker — now eyeing ₹200 Cr wagon manufacturing bet

Energy

Positron Energy Ltd

Three oil & gas veterans build India's asset-light gas aggregation platform — 39x revenue in 3 years with zero capex

Logistics

S J Logistics (India) Ltd

From freight broker to vessel operator — 3.4x revenue in 2 years with expanding margins

Aerospace & Defence

TechEra Engineering (India) Ltd

Building the tools that build India's fighter jets — from Tejas to C-295 to Rafale

Engineering Services

Telge Projects Limited

India's asset-light BIM engineering powerhouse with 33% EBITDA margins and 3.4x revenue growth in 2 years

Building Materials

Vigor Plast India Limited

The fittings-first PVC pipe brand earning 30% EBITDA margins where peers earn 12-15%

Food Processing

TBI Corn Limited

India's largest dry corn miller supplying ITC, Prataap Snacks & Balaji Wafers

Food Processing

MRP Agro Limited

Tikamgarh's dal mill story — ₹44 Cr → ₹104 Cr in one year, completely debt-free